Terms: = Lung cancer AND ATF1, TREB36, 466, ENSG00000123268, P18846 AND Prognosis
33 results:
1. lung cancer outcomes in the elderly: potential disparity in screening.
Singh A; Mazzola E; Xie Y; Marshall MB; Jaklitsch MT; Wilder FG
Eur J Cardiothorac Surg; 2024 Mar; 65(3):. PubMed ID: 38445715
[TBL] [Abstract] [Full Text] [Related]
2. Primary pulmonary myxoid sarcoma with EWSR1::CREB1 fusion: a literature review.
Miao X; Chen J; Yang L; Lu H
J Cancer Res Clin Oncol; 2024 Feb; 150(3):108. PubMed ID: 38421462
[TBL] [Abstract] [Full Text] [Related]
3. Is there a prognostic difference among stage I lung adenocarcinoma patients with different BRAF-mutation status?
Ma SS; Wang RR; Peng Q; Liu Y; Qian JY; Li MJ; Li K; Huang ZY; Wu LL; Xie D
Thorac Cancer; 2024 Mar; 15(9):715-721. PubMed ID: 38362771
[TBL] [Abstract] [Full Text] [Related]
4. Development and validation of a clinic-radiological model to predict tumor spread through air spaces in stage I lung adenocarcinoma.
Gao Z; An P; Li R; Wu F; Sun Y; Wu J; Yang G; Wang Z
Cancer Imaging; 2024 Feb; 24(1):25. PubMed ID: 38336821
[TBL] [Abstract] [Full Text] [Related]
5. Clinical, Genomic, and Transcriptomic Featurses of lung Adenocarcinoma With Uncommon EGFR Mutation.
Hayasaka K; Takeda H; Sakurada A; Matsumura Y; Abe J; Shiono S; Notsuda H; Suzuki H; Endo M; Motohashi H; Okada Y
Clin Lung Cancer; 2024 Jan; 25(1):e43-e51. PubMed ID: 37985312
[TBL] [Abstract] [Full Text] [Related]
6. The characteristics and survival of second primary lung cancer after Hodgkin's lymphoma: A comparison with first primary lung cancer using the SEER database.
Lin L; Wang D; Chen H
PLoS One; 2023; 18(5):e0285766. PubMed ID: 37195975
[TBL] [Abstract] [Full Text] [Related]
7. atf1 promotes the malignancy of lung adenocarcinoma cells by transcriptionally regulating ZNF143 expression.
Mei J; Liu Y; Sheng Y; Liu Y; Chen L; Wang H; Cheng M; Zhai Z; Xu L
Acta Biochim Biophys Sin (Shanghai); 2023 May; 55(5):769-782. PubMed ID: 37158648
[TBL] [Abstract] [Full Text] [Related]
8. Antimuscarinics and lung cancer survival: A Norwegian population-based cohort study.
Sanjinez C; Botteri E; Støer NC; Lukas Löfling L
Lung Cancer; 2023 May; 179():107187. PubMed ID: 37060880
[TBL] [Abstract] [Full Text] [Related]
9. Clinical profiles and intraoperative identification of complex glands in stage I lung adenocarcinoma.
Ding Q; Chen D; Shen S; Wang W; Chen L; Duan S; Chen Y
Eur J Cardiothorac Surg; 2023 Mar; 63(3):. PubMed ID: 36825852
[TBL] [Abstract] [Full Text] [Related]
10. MLL4 Regulates the Progression of Non-Small-Cell lung cancer by Regulating the PI3K/AKT/SOX2 Axis.
Yang Y; Qiu R; Weng Q; Xu Z; Song J; Zhao S; Meng M; Zhang D; Kong C; Wang H; Xu M; Zhao Z; Ji J
Cancer Res Treat; 2023 Jul; 55(3):778-803. PubMed ID: 36701842
[TBL] [Abstract] [Full Text] [Related]
11. Predictive factors and prognosis of microscopic residual disease in non-small-cell lung cancer surgery.
Rabinel P; Vergé R; Cazaux M; Mazzoni L; Renaud C; Rouch A; Brouchet L
Eur J Cardiothorac Surg; 2022 Sep; 62(4):. PubMed ID: 35147671
[TBL] [Abstract] [Full Text] [Related]
12. [Efficacy of 1 384 cases of peritoneal carcinomatosis underwent cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy].
Yu Y; Li XB; Lin YL; Ma R; Ji ZH; Zhang YB; An SL; Liu G; Yang XJ; Li Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Mar; 24(3):230-239. PubMed ID: 34645167
[No Abstract] [Full Text] [Related]
13. [Clinicopathological features and molecular genetic changes of lung salivary gland-type clear cell carcinoma].
Xue QQ; Huang Y; Zuo SY; Zheng Q; Ji G; Zhou XY; Wu CY; Li Y
Zhonghua Bing Li Xue Za Zhi; 2021 Jul; 50(7):728-733. PubMed ID: 34405605
[No Abstract] [Full Text] [Related]
14. LINC00355 promoted the progression of lung squamous cell carcinoma through regulating the miR-466/LYAR axis.
Sun X; Wang G; Ding P; Li S
Braz J Med Biol Res; 2020; 53(12):e9317. PubMed ID: 33111744
[TBL] [Abstract] [Full Text] [Related]
15. LINC01354 enhances the proliferation and invasion of lung cancer cells by regulating miR-340-5p/atf1 signaling pathway.
Yang G; Yang C; She Y; Shen Z; Gao P
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):3737-3744. PubMed ID: 31538498
[TBL] [Abstract] [Full Text] [Related]
16. Choice of surgical procedure - lobectomy, segmentectomy, or wedge resection - for patients with stage T1-2N0M0 small cell lung cancer: A population-based study.
Liu Y; Shan L; Shen J; Liu L; Wang J; He J; He Q; Jiang L; Guo M; Chen X; Zeng H; Xia X; Peng G; Liang W; He J
Thorac Cancer; 2019 Apr; 10(4):593-600. PubMed ID: 30854808
[TBL] [Abstract] [Full Text] [Related]
17. Establishment and Characterization of a Novel Human Clear-cell Sarcoma of Soft-tissue Cell Line, RSAR001, Derived from Pleural Effusion of a Patient with Pleural Dissemination.
Hakozaki M; Tamura H; Dobashi Y; Yoshida A; Kato K; Tajino T; Yamada H; Kaneuchi Y; Katahira K; Ezaki J; Waguri S; Konno S; Watanabe S
Anticancer Res; 2018 Sep; 38(9):5035-5042. PubMed ID: 30194147
[TBL] [Abstract] [Full Text] [Related]
18. Prognostic value of metformin for non-small cell lung cancer patients with diabetes.
Xu T; Li D; He Y; Zhang F; Qiao M; Chen Y
World J Surg Oncol; 2018 Mar; 16(1):60. PubMed ID: 29558957
[TBL] [Abstract] [Full Text] [Related]
19. Risk factors for local recurrence after total en bloc spondylectomy for metastatic spinal tumors: A retrospective study.
Igarashi T; Murakami H; Demura S; Kato S; Yoshioka K; Yokogawa N; Tsuchiya H
J Orthop Sci; 2018 May; 23(3):459-463. PubMed ID: 29429888
[TBL] [Abstract] [Full Text] [Related]
20. Feasibility Study of Personalized Peptide Vaccination for Advanced Small Cell lung cancer.
Sakamoto S; Yamada T; Terazaki Y; Yoshiyama K; Sugawara S; Takamori S; Matsueda S; Shichijo S; Yamada A; Noguchi M; Itoh K; Hattori N; Kohno N; Sasada T
Clin Lung Cancer; 2017 Nov; 18(6):e385-e394. PubMed ID: 28416261
[TBL] [Abstract] [Full Text] [Related]
[Next]
